Literature DB >> 10642736

Regression analysis of metabolite concentrations estimated from localized proton MR spectra of active and chronic multiple sclerosis lesions.

G Helms1, L Stawiarz, P Kivisäkk, H Link.   

Abstract

Localized short echo time magnetic resonance (MR) spectra were obtained from patients with multiple sclerosis of relapsing-remitting or secondary chronic-progressive course and from healthy controls. Automated analysis using model spectra, sensitivity correction, and subtraction of partial ventricular volume yielded tissue concentrations of metabolites that were in line with findings of previous studies. Additional findings were increased creatine in chronic lesions and increased myo-inositol in normal-appearing white matter. Regression analysis was performed to reveal concomitant changes of metabolite concentrations. Differences in the correlations between cholines and myo-inositol suggest increased expression of myo-inositol in chronic lesions or of cholines in active, contrast-enhanced lesions. A correlation between N-acetyl-aspartate and creatine, which is probably due to extracellular edema, was observed in active but not in chronic lesions. Creatine and cholines correlated in chronic lesions, which may be the result of gliosis. The consequences of these findings for the interpretation of absolute concentrations and creatine ratios are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10642736     DOI: 10.1002/(sici)1522-2594(200001)43:1<102::aid-mrm12>3.0.co;2-i

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  11 in total

1.  T2-based segmentation of periventricular paragraph sign volumes for quantification of proton magnetic paragraph sign resonance spectra of multiple sclerosis lesions.

Authors:  Gunther Helms
Journal:  MAGMA       Date:  2003-02       Impact factor: 2.310

Review 2.  Imaging of multiple sclerosis: role in neurotherapeutics.

Authors:  Rohit Bakshi; Alireza Minagar; Zeenat Jaisani; Jerry S Wolinsky
Journal:  NeuroRx       Date:  2005-04

Review 3.  Magnetic resonance imaging of myelin.

Authors:  Cornelia Laule; Irene M Vavasour; Shannon H Kolind; David K B Li; Tony L Traboulsee; G R Wayne Moore; Alex L MacKay
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

4.  Reproducibility measurement of glutathione, GABA, and glutamate: Towards in vivo neurochemical profiling of multiple sclerosis with MR spectroscopy at 7T.

Authors:  Hetty Prinsen; Robin A de Graaf; Graeme F Mason; Daniel Pelletier; Christoph Juchem
Journal:  J Magn Reson Imaging       Date:  2016-06-28       Impact factor: 4.813

Review 5.  Recent advances in the neuroimaging of multiple sclerosis.

Authors:  William D Rooney; Patricia K Coyle
Journal:  Curr Neurol Neurosci Rep       Date:  2005-05       Impact factor: 5.081

6.  Normal-appearing white matter changes vary with distance to lesions in multiple sclerosis.

Authors:  H Vrenken; J J G Geurts; D L Knol; C H Polman; J A Castelijns; P J W Pouwels; F Barkhof
Journal:  AJNR Am J Neuroradiol       Date:  2006-10       Impact factor: 3.825

7.  Reduced NAA-levels in the NAWM of patients with MS is a feature of progression. A study with quantitative magnetic resonance spectroscopy at 3 Tesla.

Authors:  Fahmy Aboul-Enein; Martin Krssák; Romana Höftberger; Daniela Prayer; Wolfgang Kristoferitsch
Journal:  PLoS One       Date:  2010-07-20       Impact factor: 3.240

8.  Low choline concentrations in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans.

Authors:  M C Gustafsson; O Dahlqvist; J Jaworski; P Lundberg; A-M E Landtblom
Journal:  AJNR Am J Neuroradiol       Date:  2007-08       Impact factor: 3.825

9.  Reproducibility of brain metabolite concentration measurements in lesion free white matter at 1.5 T.

Authors:  Martin H J Busch; Wolfgang Vollmann; Serban Mateiescu; Manuel Stolze; Martin Deli; Marietta Garmer; Dietrich H W Grönemeyer
Journal:  BMC Med Imaging       Date:  2015-09-29       Impact factor: 1.930

10.  Brain Metabolite Changes in Patients with Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: A Two-Year Follow-Up Study.

Authors:  Dorothea Obert; Gunther Helms; Muriel B Sättler; Klaus Jung; Benedikt Kretzschmar; Mathias Bähr; Peter Dechent; Ricarda Diem; Katharina Hein
Journal:  PLoS One       Date:  2016-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.